ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CBX Cellular Goods Plc

0.375
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cellular Goods Plc LSE:CBX London Ordinary Share GB00BK964W87 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.375 0.35 0.40 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Catalog, Mail-order Houses 67k -3.31M -0.0055 -0.40 1.32M

Cellular Goods PLC Board changes (0000M)

06/01/2023 5:04pm

UK Regulatory


Cellular Goods (LSE:CBX)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Cellular Goods Charts.

TIDMCBX

RNS Number : 0000M

Cellular Goods PLC

06 January 2023

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Press release

06 January 2023

Cellular Goods PLC

('Cellular Goods' or 'the Company')

Board changes

Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, announces that Peter Wall and Simon Walters, non-executive directors, have stepped down from the Board of Directors and are leaving the Company with immediate effect.

Mr Wall has stepped down to focus on pre-existing executive management positions. Mr Walters' retirement from the Board as a NED follows Cellular's planned course of business, with Mr Walters having served on the Board as Finance Director since November 2020. The role held by Simon changed to Non-Executive Director i n September 2022 to coincide with Cellular's appointment of Bruna Nikolla as Chief Financial Officer.

The Board would like to thank the outgoing NEDs for their valuable contributions over what has been a transformational period for the business.

Following these departures, the composition of the Board is as follows: Darcy Taylor is Interim CEO and Chairman, Bruna Nikolla is Chief Financial Officer; and Misha Sher and Gill Whitty-Collins are Non-Executive Directors.

For further information please contact:

 
 Cellular Goods 
 Darcy Taylor                          via Tancredi +44 207 887 7633 
  Interim CEO and Chairman 
  Neil Thapar                           +44 787 645 5323 
  Investor Relations 
                                      ------------------------------ 
 Tennyson Securities 
                                      ------------------------------ 
 Corporate Broker & Adviser 
  Peter Krens 
  Alan Howard                            +44 207 186 9030 
                                      ------------------------------ 
 Novum Securities 
                                      ------------------------------ 
 Corporate Broker 
  Colin Rowbury 
  Jon Belliss                            +44 207 399 9427 
                                      ------------------------------ 
 Tancredi Intelligent Communication 
                                      ------------------------------ 
 Media Relations 
  Helen Humphrey 
  Gabriela Amaya Garcia                  +44 744 922 6720 
  Charlie Hobbs                          +44 791 503 5294 
  cellulargoods@tancredigroup.com        +44 789 755 7112 
                                      ------------------------------ 
 

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUNRBROOUARAR

(END) Dow Jones Newswires

January 06, 2023 12:04 ET (17:04 GMT)

1 Year Cellular Goods Chart

1 Year Cellular Goods Chart

1 Month Cellular Goods Chart

1 Month Cellular Goods Chart

Your Recent History

Delayed Upgrade Clock